Cellular Logistics

Website

Cellular Logistics, Inc.

2 Investors
Regenerative Medicine
MADISON, WI

Cellular Logistics, Inc. is a biotechnology company operating out of Madison, Wisconsin, focused on pioneering advanced regenerative therapies for patients with various cardiovascular diseases. They aim to repair damaged heart tissue and prevent heart failure, particularly in post-heart attack patients, addressing a critical need in cardiac care.

Products & Team

CFX™

Biomaterial TherapySeed

CFX™ is a cutting-edge acellular biomaterial engineered to support heart healing and curb heart failure progression. This technology activates the body's inherent repair mechanisms within damaged heart tissue, induces the development of new blood vessels, and mitigates detrimental inflammatory responses that often result in scarring. Its versatility allows to be used alone or in conjunction with other regenerative medicine approaches, boosting their effectiveness and retention in the heart.

Value Proposition

Addresses limited regenerative options for heart tissue

Pain Points

Limited options for regenerating heart tissue; need for improved cardiac outcomes; integration of regenerative therapies

Activates natural repair mechanismsStimulates new blood vessel formationReduces inflammatory responses
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
MADISON, WI
Primary headquarters

Funding History

Total Raised:
$50.0K
E

Debt Financing, Other Offering

March 2025
$350.0K
Target
Progress
14%
Raised
$50.0K
Target
$350.0K
#000168862125000001